Biora Therapeutics granted extension to regain compliance with Nasdaq08/29/2024 Biora Therapeutics granted extension to regain compliance with Nasdaq Source: Seekingalpha
ENDRA Life Sciences granted extension to regain compliance with Nasdaq continued listing requirements08/29/2024 ENDRA Life Sciences granted extension to regain compliance with Nasdaq continued listing requirements Source: Seekingalpha
